Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapiesFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 20 August 2014

References

• L.de LeceaT.S.KilduffC.PeyronThe hypocretins: hypothalamus-specific peptides with neuroexcitatory activityProc Natl Acad Sci U S A951998322327
   PubMed Web of Science ®Google Scholar
• T.SakuraiA.AmemiyaM.IshiiOrexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviorCell921998573585
   PubMed Web of Science ®Google Scholar
• M.MiedaT.SakuraiOrexin (Hypocretin) receptor agonists and antagonists for treatment of sleep disorders: rationale for development and current statusCNS Drugs2013
   Web of Science ®Google Scholar
• T.SakuraiA.AmemiyaM.IshiiOrexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviorCell921998 1 page following 696
   Web of Science ®Google Scholar
• T.HolmqvistK.E.AkermanJ.P.KukkonenOrexin signaling in recombinant neuron-like cellsFEBS Lett52620021114
   Web of Science ®Google Scholar
• N.I.CataldiV.A.Lux-LantosC.LibertunEffects of orexins A and B on expression of orexin receptors and progesterone release in luteal and granulosa ovarian cellsRegul Pept17820125663
   Google Scholar
• K.KirszM.SzczesnaE.MolikT.MisztalA.K.WojtowiczD.A.ZiebaSeasonal changes in the interactions among leptin, ghrelin, and orexin in sheepJ Anim Sci90201225242531
   Web of Science ®Google Scholar
• Y.ZhuY.MiwaA.YamanakaOrexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteinsJ Pharmacol Sci922003259266
   PubMed Web of Science ®Google Scholar
• A.GhanemiL.HeM.YanNew factors influencing G protein coupled receptors’ system functionsAlexandria J Med49201315
   Google Scholar
• A.GhanemiTargeting G protein coupled receptor-related pathways as emerging molecular therapiesSaudi Pharm J2013
   Web of Science ®Google Scholar
• J.P.KukkonenPhysiology of the orexinergic/hypocretinergic system: a revisit in 2012Am J Physiol Cell Physiol3042013C2C32
   Web of Science ®Google Scholar
• M.H.JanttiJ.PutulaP.SomerharjuM.A.FrohmanJ.P.KukkonenOX1 orexin/hypocretin receptor activation of phospholipase DBr J Pharmacol165201211091123
   Web of Science ®Google Scholar
• A.UrbanskaP.SokolowskaA.Woldan-TamborOrexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal culturesJ Mol Neurosci MN4620121017
   Web of Science ®Google Scholar
• M.A.SteinerH.LecourtF.JenckThe dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the ratInt JNeuropsychopharmacol162013417432
   Web of Science ®Google Scholar
• R.M.ChemelliJ.T.WillieC.M.SintonNarcolepsy in orexin knockout mice: molecular genetics of sleep regulationCell981999437451
   PubMed Web of Science ®Google Scholar
• L.LinJ.FaracoR.LiThe sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 geneCell981999365376
   PubMed Web of Science ®Google Scholar
• S.NishinoB.RipleyS.OvereemG.J.LammersE.MignotHypocretin (orexin) deficiency in human narcolepsyLancet35520003940
   PubMed Web of Science ®Google Scholar
• C.J.WinrowA.L.GotterC.D.CoxPharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomniaNeuropharmacology622012978987
   PubMed Web of Science ®Google Scholar
• C.Brisbare-RochJ.DingemanseR.KobersteinPromotion of sleep by targeting the orexin system in rats, dogs and humansNat Med132007150155
   PubMed Web of Science ®Google Scholar
• B.A.KummangalD.KumarH.N.MallickIntracerebroventricular injection of orexin-2 receptor antagonist promotes REM sleepBehav Brain Res23720135962
   Web of Science ®Google Scholar
• C.B.SaperT.C.ChouT.E.ScammellThe sleep switch: hypothalamic control of sleep and wakefulnessTrends Neurosci242001726731
   PubMed Web of Science ®Google Scholar
• K.YoshidaS.McCormackR.A.EspanaA.CrockerT.E.ScammellAfferents to the orexin neurons of the rat brainJ Comp Neurol4942006845861
   PubMed Web of Science ®Google Scholar
• K.K.WongS.Y.NgL.T.LeeH.K.NgB.K.ChowOrexins and their receptors from fish to mammals: a comparative approachGen Comp Endocrinol1712011124130
   PubMed Web of Science ®Google Scholar
• J.P.KukkonenT.HolmqvistS.AmmounK.E.AkermanFunctions of the orexinergic/hypocretinergic systemAm J Physiol Cell Physiol2832002C15671591
   PubMed Web of Science ®Google Scholar
• B.BoutrelP.J.KennyS.E.SpecioRole for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behaviorProc Natl Acad Sci U S A10220051916819173
   PubMed Web of Science ®Google Scholar
• G.C.HarrisM.WimmerG.Aston-JonesA role for lateral hypothalamic orexin neurons in reward seekingNature4372005556559
   PubMed Web of Science ®Google Scholar
• W.WangY.PanQ.LiWang L.OrexA potential role in the process of obstructive sleep apneaPeptides2013
   Web of Science ®Google Scholar
• K.IigayaJ.HoriuchiL.M.McDowallBlockade of orexin receptors with Almorexant reduces cardiorespiratory responses evoked from the hypothalamus but not baro- or chemoreceptor reflex responsesAm J Physiol Regul Integr Comp Physiol3032012R10111022
   Web of Science ®Google Scholar
• W.WangQ.LiY.PanD.ZhuL.WangInfluence of hypercapnia on the synthesis of neuropeptides and their receptors in murine brainRespirology182013102107
   Web of Science ®Google Scholar
• S.L.BorglandM.A.UnglessA.BonciConvergent actions of orexin/hypocretin and CRF on dopamine neurons: emerging players in addictionBrain Res13142010139144
   Web of Science ®Google Scholar
• A.J.LawrenceM.S.CowenH.J.YangF.ChenB.OldfieldThe orexin system regulates alcohol-seeking in ratsBr J Pharmacol1482006752759
   PubMed Web of Science ®Google Scholar
• M.NaritaY.NagumoS.HashimotoDirect involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphineJ Neurosci262006398405
   PubMed Web of Science ®Google Scholar
• J.A.HollanderQ.LuM.D.CameronT.M.KameneckaP.J.KennyInsular hypocretin transmission regulates nicotine rewardProc Natl Acad Sci U S A10520081948019485
   PubMed Web of Science ®Google Scholar
• J.K.RichardsJ.A.SimmsP.SteenslandInhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans ratsPsychopharmacology1992008109117
   Web of Science ®Google Scholar
• G.Aston-JonesR.J.SmithD.E.MoormanK.A.RichardsonRole of lateral hypothalamic orexin neurons in reward processing and addictionNeuropharmacology56Suppl. 12009112121
   Google Scholar
• B.JuppB.KrivdicE.KrstewA.J.LawrenceThe orexin receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in ratsBrain Res139120115459
   Web of Science ®Google Scholar
• N.CannellaM.KallupiB.RuggeriR.CiccocioppoM.UbaldiThe role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmissionProg Neurobiol10020134859
   PubMed Web of Science ®Google Scholar
• J.W.YeohM.H.JamesP.JoblingJ.S.BainsB.A.GrahamC.V.DayasCocaine potentiates excitatory drive in the perifornical/lateral hypothalamusJ Physiol590201236773689
   Web of Science ®Google Scholar
• Y.RaoY.S.MineurG.GanRepeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin/orexin neurons in the lateral hypothalamus in miceJ Physiol2013
   Web of Science ®Google Scholar
• H.A.ErkenG.ErkenO.GencOrexins cause epileptic activityPeptides372012161164
   Web of Science ®Google Scholar
• J.R.BarsonO.KaratayevV.GaysinskayaG.Q.ChangS.F.LeibowitzEffect of dietary fatty acid composition on food intake, triglycerides, and hypothalamic peptidesRegul Pept17320121320
   Google Scholar
• A.WallH.VolkoffEffects of fasting and feeding on the brain mRNA expressions of orexin, tyrosine hydroxylase (TH), PYY and CCK in the Mexican blind cavefish (Astyanax fasciatus mexicanus)Gen Comp Endocrinol183C20134452
   Google Scholar
• S.HaradaY.YamazakiS.TokuyamaOrexin-A suppresses postischemic glucose intolerance and neuronal damage through hypothalamic brain-derived neurotrophic factorJ Pharmacol Exper Ther3442013276285
   Web of Science ®Google Scholar
• E.YilmazO.CelikN.CelikMaternal and fetal serum orexin-A levels in gestational diabetes mellitusJ Obst Gynaecol Res392013139145
   Web of Science ®Google Scholar
• M.LopezM.Tena-SempereC.DieguezCross-talk between orexins (hypocretins) and the neuroendocrine axes (hypothalamic-pituitary axes)Front Neuroendocrinol312010113127
   Web of Science ®Google Scholar
• C.J.MaddenD.TuponeS.F.MorrisonOrexin modulates brown adipose tissue thermogenesisBiomol Concepts32012381386
   Google Scholar
• C.E.Perez-LeightonK.BolandJ.A.TeskeC.BillingtonC.M.KotzBehavioral responses to orexin, orexin receptor gene expression, and spontaneous physical activity contribute to individual sensitivity to obesityAm J Physiol Endocrinol Metab3032012E865E874
   PubMed Web of Science ®Google Scholar
• M.SkrzypskiP.KaczmarekT.T.LeEffects of orexin A on proliferation, survival, apoptosis and differentiation of 3T3-L1 preadipocytes into mature adipocytesFEBS Lett586201241574164
   Web of Science ®Google Scholar
• C.PeyronD.K.TigheA.N.van den PolNeurons containing hypocretin (orexin) project to multiple neuronal systemsJ Neurosci181998999610015
   PubMed Web of Science ®Google Scholar
• X.Y.ZhangL.YuQ.X.ZhuangJ.N.ZhuJ.J.WangCentral functions of the orexinergic systemNeurosci Bull2013
   Web of Science ®Google Scholar
• A.Jawiarczyk-PrzybylowskaM.BolanowskiThe role of orexin A in metabolic disturbances in patients with acromegalyEndokrynol Pol632012463469
   Web of Science ®Google Scholar
• F.XiaoM.JiangD.DuOrexin A regulates cardiovascular responses in stress-induced hypertensive ratsNeuropharmacology6720131624
   PubMed Web of Science ®Google Scholar
• G.M.StettnerL.KubinAntagonism of orexin receptors in the posterior hypothalamus reduces hypoglossal and cardiorespiratory excitation from the perifornical hypothalamusJ Appl Physiol1142013119130
   Web of Science ®Google Scholar
• M.F.WuR.NienhuisN.MaidmentH.A.LamJ.M.SiegelCerebrospinal fluid hypocretin (orexin) levels are elevated by play but are not raised by exercise and its associated heart rate, blood pressure, respiration or body temperature changesArch Ital Biol1492011492498
   Web of Science ®Google Scholar
• X.XiongR.E.WhiteL.XuMitigation of murine focal cerebral ischemia by the hypocretin/orexin system is associated with reduced inflammationStroke J Cereb Circ2013
   Google Scholar
• J.IqbalS.PompoloT.SakuraiI.J.ClarkeEvidence that orexin-containing neurones provide direct input to gonadotropin-releasing hormone neurones in the ovine hypothalamusJ Neuroendocrinol13200110331041
   PubMed Web of Science ®Google Scholar
• L.MartynskaJ.PolkowskaE.Wolinska-WitortOrexin A and its role in the regulation of the hypothalamo-pituitary axes in the ratReprod Biol6Suppl 220062935
   Google Scholar
• S.PuM.R.JainP.S.KalraS.P.KalraOrexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent mannerRegul Pept781998133136
   PubMedGoogle Scholar
• R.SassonR.K.DearthR.S.WhiteP.E.ChappellP.L.MellonOrexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neuronsNeuroendocrinology842006353363
   PubMed Web of Science ®Google Scholar
• S.TafuriL.M.PavoneR.Lo MutoExpression of orexin A and its receptor 1 in the rat epididymisRegul Pept155200915
   Google Scholar
• S.ZhangD.BlacheP.E.VercoeExpression of orexin receptors in the brain and peripheral tissues of the male sheepRegul Pept12420058187
   PubMedGoogle Scholar
• M.L.BarreiroR.PinedaV.M.NavarroOrexin 1 receptor messenger ribonucleic acid expression and stimulation of testosterone secretion by orexin-A in rat testisEndocrinology145200422972306
   Web of Science ®Google Scholar
• A.VerrottiA.Di FonzoS.AgostinelliG.CoppolaM.MargiottaP.ParisiObese children suffer more often from migraineActa Paediatr1012012e416421
   PubMed Web of Science ®Google Scholar
• J.M.SiegelHypocretin (orexin): role in normal behavior and neuropathologyAnnu Rev Psychol552004125148
   PubMed Web of Science ®Google Scholar
• A.AdamantidisL.de LeceaThe hypocretins as sensors for metabolism and arousalJ Physiol58720093340
   Web of Science ®Google Scholar
• L.ChenJ.T.McKennaY.BolortuyaR.E.BrownR.W.McCarleyKnockdown of orexin type 2 receptor in the lateral pontomesencephalic tegmentum of rats increases REM sleepEur J Neurosci2013
   Web of Science ®Google Scholar
• J.Santamaria-CanoDiagnostic and therapeutic update in narcolepsyRev Neurol54Suppl 32012S2530
   Google Scholar
• S.OvereemT.E.ScammellG.J.LammersHypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsyCurr Opin Neurol152002739745
   PubMed Web of Science ®Google Scholar
• M.NolletP.GaillardA.TantiV.GiraultC.BelzungS.LemanNeurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depressionNeuropsychopharmacology37201222102221
   PubMed Web of Science ®Google Scholar
• A.J.RoeckerP.J.ColemanOrexin receptor antagonists: medicinal chemistry and therapeutic potentialCurr Top Med Chem82008977987
   PubMed Web of Science ®Google Scholar
• J.PutulaP.M.TurunenM.H.JanttiM.E.EkholmJ.P.KukkonenAgonist ligand discrimination by the two orexin receptors depends on the expression systemNeurosci Lett49420115760
   Web of Science ®Google Scholar
• J.PutulaJ.P.KukkonenMapping of the binding sites for the OX1 orexin receptor antagonist, SB-334867, using orexin/hypocretin receptor chimaerasNeurosci Lett5062012111115
   Web of Science ®Google Scholar
• M.A.AkanmuK.HondaSelective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving ratsBrain Res10482005138145
   PubMed Web of Science ®Google Scholar
• M.G.LeeO.K.HassaniB.E.JonesDischarge of identified orexin/hypocretin neurons across the sleep-waking cycleJ Neurosci25200567166720
   PubMed Web of Science ®Google Scholar
• I.V.EstabrookeM.T.McCarthyE.KoFos expression in orexin neurons varies with behavioral stateJ Neurosci21200116561662
   PubMed Web of Science ®Google Scholar
• J.A.ChristopherM.S.CongreveTreatment and prevention of various therapeutic conditions using OX receptor antagonistic activity (WO2012081692)Expert Opin Ther Pat232013273277
   Web of Science ®Google Scholar
• T.FujimotoY.TomataJ.KunitomoM.HirozaneS.MaruiDiscovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonistsBioorg Med Chem Lett21201164096413
   Google Scholar
• C.DugovicJ.E.SheltonL.E.AluisioBlockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the ratJ Pharmacol Exp Ther3302009142151
   PubMed Web of Science ®Google Scholar
• Y.DauvilliersC.MorinK.CervenaFamily studies in insomniaJ Psychosom Res582005271278
   PubMed Web of Science ®Google Scholar
• R.M.BencaDiagnosis and treatment of chronic insomnia: a reviewPsychiatr Serv562005332343
   PubMed Web of Science ®Google Scholar
• D.J.FoleyA.A.MonjanS.L.BrownE.M.SimonsickR.B.WallaceD.G.BlazerSleep complaints among elderly persons: an epidemiologic study of three communitiesSleep181995425432
   PubMed Web of Science ®Google Scholar
• N.S.KamelJ.K.GammackInsomnia in the elderly: cause, approach, and treatmentAm J Med1192006463469
   PubMed Web of Science ®Google Scholar
• K.ManabeT.MatsuiM.YamayaSleep patterns and mortality among elderly patients in a geriatric hospitalGerontology462000318322
   PubMed Web of Science ®Google Scholar
• T.RothNew developments for treating sleep disordersJ Clin Psychiatry62Suppl. 10200134
   PubMed Web of Science ®Google Scholar
• L.StanerComorbidity of insomnia and depressionSleep Med Rev1420103546
   PubMed Web of Science ®Google Scholar
• A.CamineroM.BartolomeSleep disturbances in multiple sclerosisJ Neurol Sci30920118691
   Web of Science ®Google Scholar
• S.SullivanUpdate on emerging drugs for insomniaExpert Opin Emerg Drugs172012295298
   PubMed Web of Science ®Google Scholar
• R.Y.MooreE.A.AbrahamsonA.Van Den PolThe hypocretin neuron system: an arousal system in the human brainArch Ital Biol1392001195205
   PubMed Web of Science ®Google Scholar
• T.NambuT.SakuraiK.MizukamiY.HosoyaM.YanagisawaK.GotoDistribution of orexin neurons in the adult rat brainBrain Res8271999243260
   PubMed Web of Science ®Google Scholar
• J.P.NixonL.SmaleA comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodentsBehav Brain Funct3200728
   PubMed Web of Science ®Google Scholar
• Y.DateY.UetaH.YamashitaOrexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systemsProc Natl Acad Sci U S A961999748753
   PubMed Web of Science ®Google Scholar
• D.J.CutlerR.MorrisV.SheridharDifferential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cordPeptides20199914551470
   PubMed Web of Science ®Google Scholar
• Y.DateM.S.MondalS.MatsukuraDistribution of orexin/hypocretin in the rat median eminence and pituitaryBrain Res Mol Brain Res76200016
   Google Scholar
• M.ShibataM.S.MondalY.DateM.NakazatoH.SuzukiY.UetaDistribution of orexins-containing fibers and contents of orexins in the rat olfactory bulbNeurosci Res61200899105
   Web of Science ®Google Scholar
• M.J.WanatF.W.HopfG.D.StuberP.E.PhillipsA.BonciCorticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of IhJ Physiol586200821572170
   PubMed Web of Science ®Google Scholar
• R.E.BrownO.SergeevaK.S.ErikssonH.L.HaasOrexin A excites serotonergic neurons in the dorsal raphe nucleus of the ratNeuropharmacology402001457459
   PubMed Web of Science ®Google Scholar
• K.TakahashiY.KoyamaY.KayamaM.YamamotoEffects of orexin on the laterodorsal tegmental neuronesPsychiatry Clin Neurosci562002335336
   Web of Science ®Google Scholar
• T.M.KorotkovaO.A.SergeevaK.S.ErikssonH.L.HaasR.E.BrownExcitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretinsJ Neurosci232003711
   PubMed Web of Science ®Google Scholar
• M.A.UnglessV.SinghT.L.CrowderR.YakaD.RonA.BonciCorticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neuronsNeuron392003401407
   PubMed Web of Science ®Google Scholar
• S.L.BorglandS.A.TahaF.SartiH.L.FieldsA.BonciOrexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaineNeuron492006589601
   PubMed Web of Science ®Google Scholar
• T.M.KorotkovaR.E.BrownO.A.SergeevaA.A.PonomarenkoH.L.HaasEffects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the ratEur J Neurosci23200626772685
   PubMed Web of Science ®Google Scholar
• J.W.MuschampJ.M.DominguezS.M.SatoR.Y.ShenE.M.HullA role for hypocretin (orexin) in male sexual behaviorJ Neurosci27200728372845
   PubMed Web of Science ®Google Scholar
• B.WangY.ShahamD.ZitzmanS.AzariR.A.WiseZ.B.YouCocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seekingJ Neurosci25200553895396
   PubMed Web of Science ®Google Scholar
• B.WangZ.B.YouR.A.WiseReinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor networkBiol Psychiatry652009857862
   Web of Science ®Google Scholar
• P.J.ColemanJ.J.RengerOrexin receptor antagonists: a review of promising compounds patented since 2006Expert Opin Ther Pat202010307324
   PubMed Web of Science ®Google Scholar
• D.SmartC.Sabido-DavidS.J.BroughSB-334867-A: the first selective orexin-1 receptor antagonistBr J Pharmacol132200111791182
   PubMed Web of Science ®Google Scholar
• J.ChalmeauC.le GrimellecJ.SternickC.VieuPatterned domains of supported phospholipid bilayer using microcontact printing of Pll-g-PEG moleculesColloids Surf B892012188195
   PubMed Web of Science ®Google Scholar
• C.J.WinrowA.L.GotterC.D.CoxPromotion of sleep by suvorexant-a novel dual orexin receptor antagonistJ Neurogenet2520115261
   PubMed Web of Science ®Google Scholar
• H.SunW.P.KennedyD.WilbrahamEffects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy menSleep362013259267
   PubMed Web of Science ®Google Scholar
• C.D.CoxM.J.BreslinD.B.WhitmanDiscovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H–1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomniaJ Med Chem53201053205332
   PubMed Web of Science ®Google Scholar
• B.D.BrielmaierEszopiclone (Lunesta): a new nonbenzodiazepine hypnotic agentProc (Bayl Univ Med Cent)1920065459
   PubMedGoogle Scholar
• M.DaviesJ.G.NewellJ.M.DerryI.L.MartinS.M.DunnCharacterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptorsMol Pharmacol582000756762
   PubMed Web of Science ®Google Scholar
• W.V.McCallM.ErmanA.D.KrystalA polysomnography study of eszopiclone in elderly patients with insomniaCurr Med Res Opin22200616331642
   PubMed Web of Science ®Google Scholar
• T.RothJ.K.WalshA.KrystalT.WesselT.A.RoehrsAn evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomniaSleep Med62005487495
   PubMed Web of Science ®Google Scholar
• M.ScharfM.ErmanR.RosenbergA 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomniaSleep282005720727
   PubMed Web of Science ®Google Scholar
• C.N.SoaresH.JoffeR.RubensJ.CaronT.RothL.CohenEszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trialObstet Gynecol108200614021410
   PubMed Web of Science ®Google Scholar
• J.K.WalshA.D.KrystalD.A.AmatoNightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitationsSleep302007959968
   PubMed Web of Science ®Google Scholar
• N.L.HarrisonMechanisms of sleep induction by GABA(A) receptor agonistsJ Clin Psychiatry68Suppl 52007612
   PubMedGoogle Scholar
• T.RothA physiologic basis for the evolution of pharmacotherapy for insomniaJ Clin Psychiatry68Suppl 520071318
   Google Scholar
• F.MicheliM.AntoliniR.Di FabioA.PellacaniA.Pozzan2-Methyl-3-furanyl-4H-1,2,4-triazol-3-ylthioamides: a new class of selective orexin 2 antagonistsBioorg Med Chem Lett20201064056407
   Web of Science ®Google Scholar
• K.OhnoT.SakuraiOrexin neuronal circuitry: role in the regulation of sleep and wakefulnessFront Neuroendocrinol2920087087
   PubMed Web of Science ®Google Scholar
• M.HochP.HoeverR.TheodorJ.DingemanseAlmorexant effects on CYP3A4 activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatinEur J Clin Pharmacol2013
   Web of Science ®Google Scholar
• A.C.HaynesB.JacksonH.ChapmanA selective orexin-1 receptor antagonist reduces food consumption in male and female ratsRegul Pept9620004551
   PubMed Web of Science ®Google Scholar
• R.J.RodgersJ.C.HalfordR.L.Nunes de SouzaSB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats.Eur J Neurosci13200114441452
   PubMed Web of Science ®Google Scholar
• S.AsahiS.EgashiraM.MatsudaDevelopment of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-BBioorg Med Chem Lett132003111113
   PubMed Web of Science ®Google Scholar
• T.FujimotoJ.KunitomoY.TomataDiscovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonistsBioorg Med Chem Lett21201164146416
   Google Scholar
• C.Blanco-CenturionM.LiuR.KonadhodeD.PelluruP.J.ShiromaniEffects of orexin gene transfer in the dorsolateral pons in orexin knockout miceSleep3620133140
   PubMed Web of Science ®Google Scholar
• L.A.DellN.PatzkeA.BhagwandinOrganization and number of orexinergic neurons in the hypothalamus of two species of Cetartiodactyla: a comparison of giraffe (Giraffa camelopardalis) and harbour porpoise (Phocoena phocoena)J Chem Neuroanat44201298109
   PubMed Web of Science ®Google Scholar
• W.J.HerringE.SnyderK.BuddOrexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexantNeurology79201222652274
   PubMed Web of Science ®Google Scholar
• J.PutulaP.M.TurunenL.JohanssonOrexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinctionFEBS Lett585201113681374
   Web of Science ®Google Scholar
• C.L.WhiteY.IshiiT.MendozaEffect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesityPeptides26200523312338
   PubMed Web of Science ®Google Scholar
• A.C.HaynesH.ChapmanC.TaylorAnorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob miceRegul Pept1042002153159
   PubMed Web of Science ®Google Scholar
• J.E.KangM.M.LimR.J.BatemanAmyloid-beta dynamics are regulated by orexin and the sleep-wake cycleScience326200910051007
   PubMed Web of Science ®Google Scholar
• P.L.JohnsonW.TruittS.D.FitzA key role for orexin in panic anxietyNat Med162010111115
   PubMed Web of Science ®Google Scholar
• L.de LeceaB.E.JonesB.BoutrelAddiction and arousal: alternative roles of hypothalamic peptidesJ Neurosci2620061037210375
   PubMed Web of Science ®Google Scholar
• M.TabaeizadehR.Motiei-LangroudiH.MirbahaThe differential effects of OX1R and OX2R selective antagonists on morphine conditioned place preference in naive versus morphine-dependent miceBehav Brain Res23720134148
   PubMed Web of Science ®Google Scholar
• A.RotterK.BayerleinM.HansbauerOrexin A expression and promoter methylation in patients with cannabis dependence in comparison to nicotine-dependent cigarette smokers and nonsmokersNeuropsychobiology662012126133
   Web of Science ®Google Scholar
• A.W.BruijnzeelTobacco addiction and the dysregulation of brain stress systemsNeurosci Biobehav Rev36201214181441
   Web of Science ®Google Scholar
• A.Plaza-ZabalaA.FloresR.MaldonadoF.BerrenderoHypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawalBiol Psychiatry712012214223
   Web of Science ®Google Scholar
• R.J.RodgersF.L.WrightN.F.SnowL.J.TaylorOrexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naive or plus-maze-experienced miceBehav Brain Res2013
   Web of Science ®Google Scholar
• L.LionettoA.NegroS.PalmisaniEmerging treatment for chronic migraine and refractory chronic migraineExpert Opin Emerg Drugs172012393406
   PubMed Web of Science ®Google Scholar
• A.GhanemiBiological properties and perspective applications of “Bio-neuter” chemicals?Saudi Pharm J22201412
   Web of Science ®Google Scholar
• A.GhanemiToward overcoming the challenges facing biomedical analysesAlexandria J Med5132015277278
   Web of Science ®Google Scholar
• A.GhanemiIs mapping borders between pharmacology and toxicology a necessity?Saudi Pharm J2014
   Web of Science ®Google Scholar
• A.GhanemiCell cultures in drug development: Applications, challenges and limitationsSaudi Pharm J2014
   Web of Science ®Google Scholar
• A.GhanemiB.BoubertakhShorter and sturdier bridges between traditional Chinese medicines and modern pharmacologySaudi Pharm J2014
   Web of Science ®Google Scholar
• B.BoubertakhX.-G.LiuX.-L.ChengP.LiA spotlight on chemical constituents and pharmacological activities of Nigella glandulifera Freyn et Sint seedsJ Chem2013201312
   Web of Science ®Google Scholar
• A.GhanemiPsychiatric neural networks and neuropharmacology: Selected advances and novel implicationsSaudi Pharm J22201495100
   Web of Science ®Google Scholar
• A.GhanemiSchizophrenia and Parkinson’s disease: selected therapeutic advances beyond the dopaminergic etiologiesAlexandria J Med492013287291
   Google Scholar